Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen

American Journal of Pathology

Volumn 185, Issue 2, 2015, Pages 432-445

  Harding, Jeffrey ^a,b   Ritter, Anna ^a   Rayasam, Aditya ^a   Fabry, Zsuzsanna ^a,b   Sandor, Matyas ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Neuroscience Training Program ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM ANTIGEN; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; GRANULOMA; GRANULOMATOSIS; HUMAN; LEUKOCYTE; LYMPHANGIOGENESIS; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUES; UPREGULATION; ANIMAL; CELLULAR IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PATHOLOGY; TUBERCULOSIS; VETERINARY;

ANIMALS; GRANULOMA; IMMUNITY, CELLULAR; LYMPHANGIOGENESIS; MICE; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES; TUBERCULOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84922329745     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.09.020     Document Type: Article

References (86)

1. Rot A, von Andrian UH: Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004, 22:891-928
2. Forster R, Davalos-Misslitz AC, Rot A: CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008, 8: 362-371
3. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, Matloubian M, Cyster JG: Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002, 169: 424-433
4. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, Pabst R, Lutz MB, Sorokin L: The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005, 22:19-29
5. Roozendaal R, Mebius RE, Kraal G: The conduit system of the lymph node. Int Immunol 2008, 20:1483-1487
6. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004, 5:74-80
7. Karpanen T, Alitalo K: Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008, 3:367-397
8. Roy H, Bhardwaj S, Yla-Herttuala S: Biology of vascular endothelial growth factors. FEBS Lett 2006, 580:2879-2887
9. Tammela T, Alitalo K: Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476
10. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001, 159:893-903
11. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, Birner P, Krieger S, Hovorka A, Silberhumer G, Laakkonen P, Petrova T, Langer B, Raab I: Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004, 15:603-612
12. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Yla-Herttuala S, Jackson DG, Alitalo K, McDonald DM: Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005, 115:247-257
13. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, Losordo DW, Streilein JW: Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005, 115:2363-2372
14. Podgrabinska S, Kamalu O, Mayer L, Shimaoka M, Snoeck H, Randolph GJ, Skobe M: Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J Immunol 2009, 183:1767-1779
15. Lukacs-Kornek V, Malhotra D, Fletcher AL, Acton SE, Elpek KG, Tayalia P, Collier AR, Turley SJ: Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat Immunol 2011, 12:1096-1104
16. Norder M, Gutierrez MG, Zicari S, Cervi E, Caruso A, Guzman CA: Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation. FASEB J 2012, 26:2835-2846
17. Cording S, Wahl B, Kulkarni D, Chopra H, Pezoldt J, Buettner M, Dummer A, Hadis U, Heimesaat M, Bereswill S, Falk C, Bode U, Hamann A, Fleissner D, Huehn J, Pabst O: The intestinal microenvironment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodes. Mucosal Immunol 2014, 7:359-368
18. Magnusson FC, Liblau RS, von Boehmer H, Pittet MJ, Lee JW, Turley SJ, Khazaie K: Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology 2008, 134:1028-1037
19. Lee JW, Epardaud M, Sun J, Becker JE, Cheng AC, Yonekura AR, Heath JK, Turley SJ: Peripheral antigen display by lymph node stroma promotes Tcell tolerance to intestinal self.Nat Immunol 2007, 8:181-190
20. Pham THM, Baluk P, Xu Y, Grigorova I, Bankovich AJ, Pappu R, Coughlin SR, McDonald DM, Schwab SR, Cyster JG: Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med 2010, 207:17-27
21. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, Coughlin SR: Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316:295-298
22. Williams GT, Williams WJ: Granulomatous inflammationea review. J Clin Pathol 1983, 36:723-733
23. Saunders BM, Cooper AM: Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 2000, 78: 334-341
24. Co DO, Hogan LH, Kim SI, Sandor M: Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clin Immunol 2004, 113:130-136
25. Russell DG: Who puts the tubercle in tuberculosis? Nat Rev Microbiol 2007, 5:39-47
26. Kauffman CA: Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 2007, 20:115-132
27. Vanek J, Schwarz J: The gamut of histoplasmosis. Am J Med 1971, 50:89-104
28. Heninger E, Hogan LH, Karman J, Macvilay S, Hill B, Woods JP, Sandor M: Characterization of the Histoplasma capsulatum-induced granuloma. J Immunol 2006, 177:3303-3313
29. Warren KS, Domingo EO, Cowan RB: Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol 1967, 51:735-756
30. Boros DL, Warren KS: Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 1970, 132: 488-507
31. Pearce EJ, MacDonald AS: The immunobiology of schistosomiasis. Nat Rev Immunol 2002, 2:499-511
32. Leader SA: Tuberculosis of the liver and gall-bladder with abscess formation: a review and case report. Ann Intern Med 1952, 37: 594-606
33. Essop AR, Posen JA, Hodkinson JH, Segal I: Tuberculosis hepatitis: a clinical review of 96 cases. Q J Med 1984, 53:465-477
34. Bengoa Hernandez R, Lopez Barbarin JM, Galdos Ayala J, Alvarez Rubio M, Delgado Fontaneda E, Garcia Campos F: [Pseudotumoral hepatic tuberculosis] Spanish. Rev Esp Enferm Dig 1994, 86: 687-689
35. Zheng MJ, Yu JL, Tian ZG: Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV. Cell Mol Immunol 2013, 10:143-150
36. Hogan LH, Macvilay K, Barger B, Co D, Malkovska I, Fennelly G, Sandor M: Mycobacterium bovis strain bacillus Calmette-Guerininduced liver granulomas contain a diverse TCR repertoire, but a monoclonal T cell population is sufficient for protective granuloma formation. J Immunol 2001, 166:6367-6375
37. Ling C, Sandor M, Suresh M, Fabry Z: Traumatic injury and the presence of antigen differentially contribute to T-cell recruitment in the CNS. J Neurosci 2006, 26:731-741
38. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999, 144: 789-801
39. Jackson DG, Prevo R, Clasper S, Banerji S: LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001, 22: 317-321
40. Jackson DG: Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004, 112:526-538
41. Yao LC, Baluk P, Feng J, McDonald DM: Steroid-resistant lymphatic remodeling in chronically inflamed mouse airways. Am J Pathol 2010, 176:1525-1541
42. Jurisic G, Iolyeva M, Proulx ST, Halin C, Detmar M: Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium. Exp Cell Res 2010, 316:2982-2992
43. Kretschmer S, Dethlefsen I, Hagner-Benes S, Marsh LM, Garn H, Konig P: Visualization of intrapulmonary lymph vessels in healthy and inflamed murine lung using CD90/Thy-1 as a marker. PLoS One 2013, 8:e55201
44. Schreiber HA, Hulseberg PD, Lee J, Prechl J, Barta P, Szlavik N, Harding JS, Fabry Z, Sandor M: Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS One 2010, 5:e11453
45. Schreiber HA, Harding JS, Hunt O, Altamirano CJ, Hulseberg PD, Stewart D, Fabry Z, Sandor M: Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 2011, 121:3902-3913
46. Sawa Y, Ueki T, Hata M, Iwasawa K, Tsuruga E, Kojima H, Ishikawa H, Yoshida S: LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J Histochem Cytochem 2008, 56:97-109
47. Sawa Y, Tsuruga E: The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides. J Anat 2008, 212:654-663
48. McKimmie CS, Singh MD, Hewit K, Lopez-Franco O, Le Brocq M, Rose-John S, Lee KM, Baker AH, Wheat R, Blackbourn DJ, Nibbs RJ, Graham GJ: An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood 2013, 121:3768-3777
49. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR Jr: Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 2003, 4:949-955
50. Kirkin V, Thiele W, Baumann P, Mazitschek R, Rohde K, Fellbrich G, Weich H, Waltenberger J, Giannis A, Sleeman JP: MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo. Int J Cancer 2004, 112:986-993
51. Achen MG, McColl BK, Stacker SA: Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005, 7:121-127
52. Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature 2005, 438:946-953
53. Tobler NE, Detmar M: Tumor and lymph node lymphangiogenesis dimpact on cancer metastasis. J Leuko Biol 2006, 80:691-696
54. Morfoisse F, Kuchnio A, Frainay C, Gomez-Brouchet A, Delisle MB, Marzi S, Helfer AC, Hantelys F, Pujol F, Guillermet-Guibert J, Bousquet C, Dewerchin M, Pyronnet S, Prats AC, Carmeliet P, Garmy-Susini B: Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1alpha-independent translation-mediated mechanism. Cell Rep 2014, 6:155-167
55. Fujiwara H, Kleinhenz ME, Wallis RS, Ellner JJ: Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 1986, 133:73-77
56. Flynn JL, Scanga CA, Tanaka KE, Chan J: Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998, 160:1796-1803
57. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989, 56:731-740
58. Zhang Y, Rom WN: Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol 1993, 13:3831-3837
59. Beltan E, Horgen L, Rastogi N: Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb Pathog 2000, 28:313-318
60. Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN: Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest 1993, 91:2076-2083
61. Reiling N, Blumenthal A, Flad HD, Ernst M, Ehlers S: Mycobacteriainduced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J Immunol 2001, 167:3339-3345
62. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ: TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 2002, 168:4620-4627
63. Engele M, Stossel LE, Castiglione K, Schwerdtner N, Wagner M, Bolcskei P, Rollinghoff M, Stenger S: Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immunol 2002, 168:1328-1337
64. Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, Maillet I, Jacobs M, Ryffel B, Quesniaux VFJ: IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol 2007, 179:1178-1189
65. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K: Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998, 273:8413-8418
66. Cha HS, Bae EK, Koh JH, Chai JY, Jeon CH, Ahn KS, Kim J, Koh EM: Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. J Rheumatol 2007, 34:16-19
67. Nakamura K, Radhakrishnan K, Wong YM, Rockson SG: Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One 2009, 4: e8380
68. Cohen B, Addadi Y, Sapoznik S, Meir G, Kalchenko V, Harmelin A, Ben-Dor S, Neeman M: Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75. Neoplasia 2009, 11:921-933
69. Chan J, Xing Y, Magliozzo RS, Bloom BR: Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992, 175:1111-1122
70. Cooper AM, Segal BH, Frank AA, Holland SM, Orme IM: Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. Infect Immun 2000, 68:1231-1234
71. Voskuil MI, Bartek IL, Visconti K, Schoolnik GK: The response of mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol 2011, 2:105
72. Chang CH, Huang YL, Shyu MK, Chen SU, Lin CH, Ju TK, Lu J, Lee H: Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. Acta Pharmacol Sin 2013, 34:360-366
73. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L: Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 2010, 327:466-469
74. Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, Basaraba RJ, Orme IM, Matrisian LM, Izzo AA: Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 2006, 74:6135-6144
75. Price NM, Gilman RH, Uddin J, Recavarren S, Friedland JS: Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks. J Immunol 2003, 171:5579-5586
76. Quiding-Jarbrink M, Smith DA, Bancroft GJ: Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001, 69:5661-5670
77. Van Kruiningen HJ, Hayes AW, Colombel JF: Granulomas obstruct lymphatics in all layers of the intestine in Crohn's disease. APMIS 2014
78. Geleff S, Schoppmann SF, Oberhuber G: Increase in podoplaninexpressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch 2003, 442:231-237
79. Fogt F, Pascha TL, Zhang PJ, Gausas RE, Rahemtulla A, Zimmerman RL: Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. Int J Mol Med 2004, 13:211-214
80. Pedica F, Ligorio C, Tonelli P, Bartolini S, Baccarini P: Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows Arch 2008, 452: 57-63
81. Rahier JF, De Beauce S, Dubuquoy L, Erdual E, Colombel JF, Jouret-Mourin A, Geboes K, Desreumaux P: Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Aliment Pharmacol Ther 2011, 34:533-543
82. Mooney EE, Walker J, Hourihane DO: Relation of granulomas to lymphatic vessels in Crohn's disease. J Clin Pathol 1995, 48: 335-338
83. Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH: Lymphatic endothelial cells induce tolerance via PDL1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 2012, 120:4772-4782
84. Humphreys IR, Stewart GR, Turner DJ, Patel J, Karamanou D, Snelgrove RJ, Young DB: A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect 2006, 8: 1339-1346
85. Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, Ioerger T, Sacchettini J, Fortune SM, Flynn JL: Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 2014, 20:75-79
86. Lin PL, Coleman T, Carney JP, Lopresti BJ, Tomko J, Fillmore D, Dartois V, Scanga C, Frye LJ, Janssen C, Klein E, Barry CE 3rd, Flynn JL: Radiologic responses in cynomolgous macaques for assessing tuberculosis chemotherapy regimens. Antimicrobial agents and chemotherapy 2013, 57:4237-4244